SpeechPathology.com Phone: 800-242-5183


EDU Healthcare Opportunities

22q11.2 Deletion Syndrome: Role of the SLP in Diagnosis, Assessment and Treatment

22q11.2 Deletion Syndrome: Role of the SLP in Diagnosis, Assessment and Treatment
Adriane Baylis, Ph.D., CCC-SLP
February 13, 2012

To earn CEUs for this article, become a member.

unlimited ceu access $129/year

Join Now
Share:

 This article is a written transcript of the course, “22q11.2 Deletion Syndrome: Role of the SLP in Diagnosis, Assessment and Treatment”, presented by Adrian Baylis, Ph.D., CCC-SLP on December 01, 2011.

>> Amy Hansen: Good afternoon, everyone.  Welcome to today's expert seminar, 22q11.2 Deletion Syndrome: Role of the SLP in Diagnosis, Assessment and Treatment presented today by Adrian Baylis.  Dr. Adrian Baylis is a speech scientist and speech‑language pathologist for the division of Plastic and Reconstructive Surgery at Nationwide Children's Hospital in Columbus, Ohio.  She serves as co‑director of the 22q Center at Nationwide Children's Hospital and also provides clinical services to the speech‑language disorders associated with cleft palate and velopharyngeal dysfunction. Dr. Baylis’ primary clinical and research interests include speech‑language disorders associated with cleft palate and velopharyngeal dysfunction, speech outcome measures, and communication disorders associated with 22q11.2 deletion syndrome.  She also serves as a lecturer for the Ohio State University and is actively involved with the American Cleft Palate Craniofacial Association and ASHA Special Interest Group 5: Speech Science and Orofacial Anomalies.  Welcome, Adrian.  Thank you so much for sharing your expertise with us today.

[Applause]

>> Adriane Baylis:  Thank you very much, Amy.  Can everyone hear me?  Okay.  We're going to move forward with our presentation today on 22q11.2 deletion syndrome and talk about diagnosis, assessment and our role in treatment.  We're going to do an overview of the syndrome and talk about the speech development profiles with children with 22q and talk about assessment and treatment guidelines. 

Before we move forward I would like everyone to look on the left side of their screen where you have the hands up box. I’d like to take a quick survey. If you could click on the thumbs up green box if you have a current child on your caseload with 22q, just to get an idea of who is in our audience today.  Some do and some did in the past. One additional question - click on the high-five box if you're currently a member of a cleft palate team or member of ACPA.  Okay.  So looks like just a few that are working in that area right now. 

To earn CEUs for this article, become a member.

unlimited ceu access $129/year

Join Now

adriane baylis

Adriane Baylis, Ph.D., CCC-SLP

Adriane Baylis, Ph.D., CCC-SLP, is Speech Scientist and Speech-Language Pathologist for the Section of Plastic and Reconstructive Surgery at Nationwide Children's Hospital (Columbus, OH). Dr. Baylis serves as Co-Director of the 22q Center at Nationwide Children’s Hospital and also provides clinical services to the Cleft Lip and Palate Center. Dr. Baylis' primary clinical and research interests include speech-language disorders associated with cleft palate and velopharyngeal dysfunction, speech outcome measures, and communication disorders associated with 22q11.2 deletion syndrome.  She also serves as a lecturer for The Ohio State University and is actively involved with American Cleft Palate-Craniofacial Association and ASHA Special Interest Group 5: Speech Science and Orofacial Anomalies.



Related Courses

20Q: Head and Neck Cancer for the Speech-Language Pathologist
Presented by Barbara Messing, PhD, CCC-SLP, BCS-S, FASHA
Text
Course: #10591Level: Advanced1 Hour
Aspects of head and neck cancer (HNC) management relevant to the speech-language pathologist considering working with this population are described in this course. Specifically, HNC diagnosis and treatment, surgical and reconstructive options, communication and swallowing issues, treatment-related toxicities, and the impact on quality of life are addressed.

20Q: Velo-Cardio-Facial Syndrome (VCFS)
Presented by Karen J. Golding-Kushner, PhD, CCC-SLP, ASHA Fellow
Text
Course: #8700Level: Intermediate1 Hour
This course describes the characteristics of Velo-cardio-facial syndrome that are of the greatest relevance to SLPs: those that affect feeding, speech and language. Best practice for intervention is also explained.

20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists
Presented by Robert Brinton Fujiki, PhD, CCC-SLP
Text
Course: #10761Level: Intermediate1 Hour
The nature of induced laryngeal obstruction, including comorbidities and causes, and the speech-language pathologist’s role in evaluation and treatment of this disorder are described in this course. Current diagnostic and treatment practices and research updates pertaining to the condition are discussed.

20Q: Pediatric Voice Disorders: Diagnostic and Treatment Approaches
Presented by Susan Baker Brehm, PhD, CCC-SLP, Barbara (Derickson) Weinrich, PhD, CCC-SLP, Lisa Nelson Kelchner, PhD, CCC-SLP, BCS-S
Text
Course: #8972Level: Introductory1 Hour
This course provides the practicing speech-language pathologist with information on special considerations in the treatment of children with voice disorders. The various causes of voice disorders are discussed as well as the treatment of specific types of disorders.

Back to Basics: Down Syndrome
Presented by Theresa Bartolotta, PhD, CCC-SLP
Video
Course: #8975Level: Introductory1 Hour
This course will serve as a primer on Down syndrome for practicing speech-language pathologists. The basics of the syndrome and common speech, language, voice and fluency issues will be addressed. Effective treatment strategies for improving communication across the lifespan will also be discussed.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.